Right ventricular diastolic dysfunction (RVDD) is an important prognostic indicator in pulmonary arterial hypertension (PAH). RV vortex rings have been observed in healthy subjects, but their significance in RVDD is unknown. Vorticity, the local spinning motion of an element of fluid, may be a sensitive measure of RV vortex dynamics. Using four-dimensional (4D) flow cardiac magnetic resonance imaging (CMR), we investigated the relationship between right heart vorticity with echocardiographic indexes of RVDD. Thirteen (13) PAH subjects and 10 controls underwent same-day 4D flow CMR and echocardiography. RV diastolic function was assessed using trans-tricuspid valve (TV) early (E) and late (A) velocities, E/A ratio, and e' and a' tissue Doppler velocities. RV and right atrial (RA) integrated mean vorticity was calculated for E and A-wave filling periods using 4D datasets. Compared with controls, A-wave vorticity was significantly increased in RVDD subjects in both the RV [2343 (1,559 -3,295) vs. 492 (267-2,649) 1/s, P ϭ 0.028] and RA [30 (27-44) vs. 9 (5-27) 1/s, P ϭ 0.005]. RA E vorticity was significantly decreased [13 (7-22) vs. 28 (15-31) 1/s, P ϭ 0.038] in RVDD. E-wave vorticity correlated TV e', E-,and TV E/A (P Ͻ 0.05), and A-wave vorticity associated with both TV A and E/A (P Ͻ 0.02). RVDD is associated with alterations in E-and A-wave vorticity, and vorticity correlates with multiple echocardiographic markers of RVDD. Vorticity may be a robust noninvasive research tool for the investigation of RV fluid and tissue mechanical interactions in PAH.
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NEW & NOTEWORTHY

This research article demonstrates for the first time that intracardiac vorticity, the local spinning motion of an element of fluid, is a sensitive marker of echocardiographic parameters of right ventricular diastolic dysfunction in a group of pulmonary hypertension patients and matched controls.
BLOOD FLOW TOPOLOGIES THROUGH the heart and major vessels have directional changes and asymmetries whose functional significance in cardiovascular disease remains relatively unexplored. Due to its potential role in the efficient transfer of kinetic energy from inflow to outflow, the vortex ring formed in the left ventricle (LV) during diastole has been extensively examined (13, 16, 33, 38) . LV vortex properties, including both formation time and strength, have been associated with LV diastolic dysfunction (1, 5) . Although similar vortex rings have also been observed in the right ventricle (RV) of healthy subjects, the significance of these structures in cardiopulmonary disease states is unknown (8, 9, 13, 24, 27) .
Recent studies have found that RV vortex structures are altered in canine models of pulmonary hypertension as well as patients with repaired tetralogy of Fallot and Fontan circulation (8, 11, 23, 28, 29) . Vorticity, the local spinning motion of an element of fluid, may be a sensitive measure of vortex dynamics. Vorticity can be present in coherent flow patterns such as helical flows and vortex rings, while shear flows may contain vorticity without exhibiting coherent vortex structures (16) . Vorticity may offer novel and robust diastolic flow characterization with potential incremental value to existing echocardiographic techniques. With the use of time-averaged phase velocity encoded acquisition in the X, Y, and Z planes, fourdimensional (4D) flow cardiac magnetic resonance imaging (CMR) can generate high-fidelity spatial and temporal renderings of these complex flow patterns while offering a novel method for quantifying vorticity.
Given the relationship between LV vortices and diastolic function, similar correlations may exist between RV vortices and RV diastolic parameters. The adaptive changes that result from chronic pressure overload in pulmonary arterial hypertension (PAH) lead to myocardial hypertrophy, stiffening, and right ventricular diastolic dysfunction (RVDD) (10) . RVDD represents a spectrum of abnormalities in RV relaxation, compliance, and filling that is defined using a combination of echocardiographic indexes including the ratio of early (E) and late (A) trans-tricuspid inflow velocities (TV E/A), early TV annular tissue Doppler velocity (TV e'), and the TV E/e' ratio (30) . A growing body of evidence has identified RVDD as an important prognostic indicator for PAH (31, 32) . The development of a robust noninvasive research tool such as 4D flow CMR for the study of right heart blood flow may improve the mechanistic understanding of RVDD and potentially PAH. Using a prospective study comparing controls to PAH subjects with RVDD, we aimed to characterize and quantify RV vorticity using the classic definition of vorticity as the curl of the velocity vector (4) . We hypothesized that 4D CMR-derived right heart vorticity correlates with echocardiographic indexes of RVDD.
METHODS
Study population. The prospective study was internal review boardapproved and informed consent was obtained from all subjects. All subjects were 18 yr or older without known cardiomyopathy, atrial fibrillation, coronary artery disease (history of myocardial infarction, prior mechanical revascularization including percutaneous coronary intervention or coronary artery bypass surgery, or known coronary artery stenosis Ͼ50%), significant (i.e., Ͼ moderate) valvular heart disease, or advanced liver disease (cirrhosis, chronic hepatitis B or C infection, or cancer). In addition, control subjects were asymptomatic without parenchymal lung disease, pulmonary hypertension, or smoking history. Before enrollment, all RVDD subjects had 1) previous right-heart catheterization-proven PAH as per World Health Organization criteria and 2) RVDD as per American Society of Echocardiography guidelines (25, 30) . Biometric data including age, gender, body mass index (BMI), systemic blood pressure, and heart rate were collected on the day of protocol performance. Right heart catheterization (RHC) was performed on all RVDD subjects within an average 152 Ϯ 223 days (range 33-519 days) before enrollment for clinical indications. Mean pulmonary artery pressure, pulmonary artery wedge pressure, and pulmonary vascular resistance were measured/calculated during RHC. RHC was not performed on controls due to ethical considerations.
2D and Doppler echocardiography. Data acquisition was performed with a Vivid 7 ultrasound system (General Electric Medical Systems, Milwaukee, WI) equipped with a 3-MHz transducer. Tissue Doppler recordings were acquired from an apical four-chamber view during a short end-expiration pause. With the use of pulsed-wave Doppler echocardiography, RV and LV filling parameters were obtained including E and A TV and mitral valve (MV) filling peak velocities, E/A ratio, and E-wave deceleration time (DT). With the use of pulsed tissue Doppler, lateral and septal tricuspid and mitral annulus early (e') and late (a') diastolic velocities were obtained as well as intraventricular relaxation time (IVRT). RV and LV size and function were assessed using 2D echocardiography in apical twochamber, three-chamber, four-chamber, and short axis views as well as the subcostal view. RVDD was defined as either stage I (TV E/A Ͻ 0.8, TV E/e' Ͼ 6, and DT Ͼ 120 ms) or stage II (TV E/A ϭ 0.8 -2.1, TV E/e' Ͼ 6, and DT Ͼ 120 ms) (20) . Right ventricular systolic pressure (RVSP) and right atrial pressure (RAP) were estimated as previously described (30, 34) . Because of the potential for right-sided valvular disease to confound vorticity analysis, tricuspid regurgitation (TR) and pulmonic regurgitation (PR) were graded as previously described using echocardiograms that were performed as part of clinical care (39) .
2D CMR. CMR was performed the same day as echocardiography. Subjects underwent CMR imaging in the supine position using a 1.5-T clinical MRI system (MAGNETOM Avanto; Siemens Healthcare Sector, Erlangen, Germany) and eight channel phased array cardiac coil. Ventricular volumetric and functional analyses were performed offline by a blinded reader using commercially available software (Argus, MR B17; Siemens Healthcare Sector). RV end-diastolic and end-systolic contours were manually traced in the axial view for each slice. RV end diastolic volume (RVEDV) and end systolic volume (RVESV) were determined according to the modified Simpson's rule (18) . RA volume was determined as previously described (19) . RV ejection fraction (RVEF), stroke volume (RV SV), cardiac output (RV CO), and cardiac index (RV CI) were also calculated. Ventricular segmentations were performed using Segment software (23) .
4D flow CMR visualization. 4D flow CMR was performed with interleaved 3-directional velocity encoding (voxel volume ϭ 11.7-20.3 mm 3 , ␣ ϭ 15°, TE/TR ϭ 2.85/48.56 ms, venc ϭ 100 cm/s, and temporal resolution ϭ 50 ms). 4D flow images were acquired using a RF-spoiled gradient echo pulse sequence, prospective ECG gating, and respiratory navigators using bellows as previously described (22).
Vorticity analysis. Raw 4D CMR phase contrast data sets were filtered for noise, anti-aliased using a custom MATLAB program, and converted to Ensight data format using the Velomap software package (33) . The RA and RV regions of interest were manually isolated by superimposing 2D CMR axial and four-chamber images (Paraview; Kitware, Clifton, NY). Vorticity vectors were thresholded to 0.03 and 0.7 1/s to remove regions of low magnitude vorticity from the integral. The integral of vorticity magnitude over the RV and RA volumes was calculated at peak E-and A-wave time steps using the cumulative sum function and multiplied by voxel volume to give the integral. To ensure the precision of computation, the peak E and A phase were identified by comparison of flow-cycle patterns in four-chamber 2D-CMR images and velocity profiles generated by 4D-CMR images.
Laboratory diagnostics. Serum was collected from all subjects via phlebotomy for brain natriuretic peptide (BNP) and creatinine measurements immediately before echocardiography and CMR. Following collection and centrifugation, samples were aliquoted and stored at Ϫ20°C as per manufacturer's instructions for use. Samples were sent to a core laboratory facility for analysis, run in triplicate, and averaged by a single blinded operator. Glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease (MDRD) Study equation (17) .
Statistical analysis. Tabular data are reported in aggregate as means Ϯ 1SD or median with interquartile range for continuous data and a percentage for categorical data. Spearman's Rho correlation coefficients were used to test the relationship between vorticity and markers of ventricular diastolic and systolic dysfunction using JMP v9.0 (SAS Insitute, Cary, NC). Statistical significance was defined as P Ͻ 0.05 [not significant (NS)]. The ShroutFleiss intraclass correlation coefficient (ICC) was utilized to assess for interobserver variability for vorticity measurement (7).
RESULTS
Patient characteristics.
There were no significant differences in age, BMI, and gender between the two groups (see Table 1 ). Only BNP and heart rate were significantly higher in the RVDD cohort compared with controls, and mean GFR was within normal limits for both groups. PAH etiologies in the RVDD cohort were either idiopathic (n ϭ 9) or systemic sclerosis-associated (n ϭ 4). PAH-specific therapies in the RVDD cohort at the time of protocol performance included sildenafil (n ϭ 6), tadalafil (n ϭ 1), and ambrisentan (n ϭ 1). Right heart pressures in the RVDD cohort were moderately elevated with a mean pulmonary artery pressure of 43.4 Ϯ 14.5 mmHg and pulmonary vascular resistance of 9.1 Ϯ 5.8 Wood's units.
Acquisition data. Temporal resolution for each 4D CMR acquisition was 50 ms. The number of acquired frames per cardiac cycle was dependent on heart rate and varied from 10 to 30 frames with an average of 17 Ϯ 5 frames. Average voxel volume for the cohort was 18.0 Ϯ 3.0 mm 3 . Assessment of RV diastolic dysfunction. Six subjects had stage I RVDD, while seven subjects had stage II RVDD. As anticipated, markers of RV diastolic function were significantly different in the RVDD group vs. controls (see Table 1 ). Both TV e' velocity and E/A ratio were significantly reduced in the RVDD cohort, while TV A velocity, RV IVRT, and TV E/e' ratio were all increased. There was no statistically significant difference in TV E velocity or DT.
Assessment of LV diastolic function. LV diastolic function was normal in all control subjects. Consistent with prior studies reporting LV diastolic dysfunction in PAH, the majority of RVDD subjects had either stage I diastolic dysfunction (n ϭ 10) or stage II diastolic dysfunction (n ϭ 2) with only one subject demonstrating normal diastolic function. Mean MV E/e' and MV A velocity were increased in the RVDD group, while septal MV e' and lateral MV e' velocities as well as MV E/A ratio were all significantly decreased in the RVDD group vs. controls (see Table 1 ). There was no difference in MV E velocity or DT.
RV morphology, function, and valvular disease. Because RV morphology and function were suspected to impact RV inflow patterns, RV volume and systolic function were assessed using 2D CMR. RVEDV, RVESV, and RVSP were all significantly increased in the RVDD group while RVEF was significantly lower in the RVDD group (see Table 1 ). There was no difference in RA volume, RV SV, CO, or CI. TR was overall mild in the pulmonary hypertension cohort (trace or mild ϭ 13, mild-moderate ϭ 3, and severe ϭ 1). Similarly, PR was trace or mild in all subjects with the exception of one pulmonary hypertension subject who demonstrated mild-moderate PR.
Qualitative description of vorticity in the right heart. Using qualitative analysis of 4D flow CMR images from a representative healthy subject, we sought to describe vorticity during diastole in a normal right heart. During late systole in the RA, flow from the superior and inferior vena cava enter the chamber tangentially (see Fig. 1 and Supplemental Video S1; Supplemental Material for this article is available online at the Journal website). Vorticity separates from the wall and is convected into the center of the chamber. During peak E-wave filling in the RV (t ecg ϭ 525 ms), there is a lack of flow recirculating behind the vorticity sheet near the inferior and superior regions of the tricuspid apparatus (see Fig. 2 ). When viewed from the short axis, a region of high vorticity wraps around TV inflow on the right and forms a three-fourths complete loop. At the end of A-wave filling (t ecg ϭ 1,127 ms), a detached vortex ring portion appears with flow circling around the vortex core. When flow patterns in RVDD subjects were compared qualitatively to controls, both RV and RA A-wave vorticity appeared overall increased. We therefore proceeded with quantitative vorticity analysis to corroborate this finding.
Vorticity analysis. When RVDD subjects were compared with controls, there was a significant increase in both integrated RV A-wave vorticity and RA A vorticity (see Fig. 3 and Supplemental Videos S2 and S3). In addition, there was a significant decrease in RA E-wave vorticity. However, there was only a trend towards a decrease in integrated RV E-wave vorticity (P ϭ 0.07). Interobserver agreement analysis for vorticity calculation was performed using the Fleiss ICC method and demonstrated an ICC value of 0.91 for RV E vorticity, 0.80 for RV A vorticity, 0.93 for RA E vorticity, and 0.96 RA A vorticity, all of which are considered excellent agreement.
Vorticity relates to echocardiographic indexes of RV diastolic function. Both RV and RA E-wave vorticity positively correlated with markers of early filling including TV E and TV e' velocities (see Table 2 ). In addition, E-wave vorticity in both chambers positively correlated with the ratio of TV E/A and negatively associated with RV IVRT. Similar to the relationship between E-wave vorticity and TV E, both RV and RA A-wave vorticity positively correlated with TV A. Conversely, RV and RA A-wave vorticity negatively correlated with TV A velocity, while only RA A vorticity associated with TV a' velocity (see Table 3 ). Neither E-nor A-wave vorticity in either chamber was associated with CO, and only RA A-wave vorticity was associated with heart rates.
Vorticity relates to echocardiographic indexes of LV diastolic function. Given the importance of ventricular interdependence in RV function in PAH, LV diastolic function was evaluated using trans-MV inflow as well as septal and lateral MV tissue Doppler velocities. Both RV E-and RA E-wave vorticity correlated with MV E velocity, while RA E vorticity associated with multiple additional markers of LV diastolic function including MV septal e' velocity and MV E/A ratio (see Table 2 ). Similarly, both RV and RA A-wave vorticity both demonstrated strong correlations with MV A and MV lateral a' velocities. Neither RV nor RA A-wave vorticity correlated with MV septal a' velocity.
Vorticity correlates with markers of RV size, systolic function, and pressure. Given the potential impact of right heart chamber size and function on vortex formation, the relationship between right heart volumes/function and vorticity was examined. E vorticity (both RV and RA) negatively correlated with RVEDV and positively correlated with RVEF. Further- more, RA E-wave vorticity correlated with RVSP, suggesting a relationship with pulmonary artery systolic pressure. However, there was no significant correlation between A-wave vorticity, either RV or RA, and RVEDV, RVEF, or RVSP. However, BNP positively correlated with RV A-wave vorticity (Rho 0.44, P ϭ 0.036) and approached a significant association with RA A vorticity (Rho ϭ 0.39, P ϭ 0.069). Because renal function would be expected to impact RV volume and function, we evaluated the relationship between GFR and vorticity. However, no significant correlations were identified between vorticity and GFR.
DISCUSSION
In this first-ever study using 4D flow CMR to evaluate right heart flow patterns, vorticity, and diastolic function, we dem- Fig. 1 . Figure 1 . Right atrial peak E-and A-wave velocity (white glyphs) and vorticity (colored glyphs) for a representative control subject (A-D) and a RVDD subject (E-H). Compared to the control subject, note that the right ventricular diastolic dysfunction (RVDD) subject demonstrates decreased right atrial E-wave vorticity glyph density and, conversely, relatively increased A-wave vorticity. RA, right atrium; TV, tricuspid valve; RV, right ventricle; SVC, superior vena cava; IVC, inferior vena cava. A, C, E, and G) and posterior (B, D, F, and H) views. Compared with control subject, note that the RVDD subject demonstrates similar RV E-wave vorticity glyph density but relatively increased A-wave vorticity.
onstrate that RVDD is associated with decreased spatially integrated right heart E and increased A-wave vorticity in a small cohort of control and PAH subjects. Both right heart E-and A-wave vorticity correlated with multiple echocardiographic markers of RVDD. Furthermore, significant correlations existed between both E-and A-wave vorticity and respective markers of LV diastolic function, suggesting a relationship between vorticity and ventricular interdependency. These findings not only demonstrate the feasibility of right heart vorticity assessment but also provide hypothesisgenerating data for the interplay between vorticity generation and RV tissue mechanics. Ultimately, vorticity analysis may prove to be a useful research tool for the investigation of ventricular dysfunction in PAH.
The interactions between tissue mechanics, hemodynamic forces, and intracardiac vorticity are clearly numerous and complex. Similar to the LV, TV E-wave velocity primarily reflects the RA-RV pressure gradient during early diastole and is affected by preload as well as RV relaxation (40) . TV A-wave velocity reflects the RA-RV pressure gradient during late diastole and is affected by RV compliance and RA contractile function. Both E-and A-wave velocities are likely impacted by a variety of factors including both RV elastic recoil and chamber inflow. Our qualitative findings indicate reduced measured RV E-wave vorticity in RVDD compared with controls. Both RV E-and A-wave vorticity correlated with elastic recoil as indicated by RV e' and a' velocities, respectively. In addition, both RV E and A vorticity were associated with RV inflow as indicated by TV E and A velocities, respectively. Surprisingly, no vorticity measurement appeared to correlate with CO or CI. Perhaps most provocative is the finding that right heart E-and A-wave vorticity correlates with pulsed wave and tissue Doppler indexes of LV diastolic function. It is well established that LV diastolic dysfunction is commonly present in PAH, and most of our PAH subjects had either stage I or II LV diastolic dysfunction (20) . The finding that both decreased RV and RA E-wave vorticity coincided with multiple echocardiographic markers of LV diastolic dysfunction may reflect this ventricular interdependency. The correlation of vorticity with parameters of diastolic function represents an initial application of quantitative intracardiac 4D flow analysis towards the development of robust noninvasive diagnostics for both RVDD and PAH. We focused on vorticity because, as a derivative quantity, we hypothesize that pathologic changes in the vorticity field are detectable prior to the onset of changes in structural or flow metrics. However, a more fundamental understanding of the interactions of flow, vorticity, and cardiac morphology is required to guide the development of specific diagnostic metrics that are derived from 4D flow measurements. These metrics may include novel methods to quantify the kinematics of the flow, including examination of streamline and pathline destinations, vortex structure identification using closed or curved streamlines and pathlines, and the -2 criterion (16, 21, 25, 28) . Quantitation of vortex structure geometry such as ring location, completeness, and circularity is also possible (16) . As the analysis in the present work suggests, decomposing the vorticity into a streamwise (helical) component and a transverse component may be fruitful in quantifying the origin and fate of intracardiac vorticity, as well as providing additional metrics to be examined for correlation to right heart pathologies. Although designating a specific element of the vorticity field or type of analysis as a key metric is premature, the results presented here support the development of these metrics. Given the identified correlations between A-wave vorticity and diastolic parameters, the most sensitive specific element of the vorticity field might include the ratio of helicity to total vorticity at peak A-wave around the tricuspid apparatus.
If changes in intracavitary vortex dynamics precede alterations in ventricular mechanics, changes in intracardiac vorticity may portend the development of negative RV remodeling associated with pulmonary vascular disease. In this way, reduced vorticity may be a marker of impending RV-pulmonary arterial hemodynamic uncoupling. Consequently, it could be postulated that pulmonary vascular disease and related states of RV remodeling are associated reduced vorticity and therapeutic interventions that improve RV afterload in pulmonary vascular disease are associated with increased vorticity. In this way, vorticity could serve as a sensitive noninvasive biomarker for the assessment for both the hemodynamic and bioenergetic response to therapy.
We acknowledge multiple limitations to our study. As a pilot study, our results are inherently limited by a small sample size, hindering the ability to derive broad conclusions about the mechanical, hemodynamic, and morphologic correlates of vorticity. Because 4D CMR requires time-averaged X, Y, and Z plane phase contrast acquisitions, our velocity data are averaged over the duration of the scan (ϳ40 -60 min) and stochastic flow characteristics are averaged out. In addition, the respiratory navigator window utilized in this study allows for a range of respiratory effort. The RV is very preload dependent, and peak TV E-and A-wave velocities are known to vary with respiration (40) . Therefore, our data reflect the average of a range of hemodynamic and respiratory events and may limit the strength of the associations we report. Furthermore, because our temporal resolution was limited to 50 ms, and since a normal diastolic period is ϳ120 -200 ms, there is potential that hemodynamic events and associated changes in vorticity were not captured by our acquisition (26) . The limited spatial resolution may also mask details of the velocity gradients and therefore of vorticity. Finally, our echocardiography protocol did not incorporate color Doppler analysis to assess the degree to which TR is present. Given the potential for TR to cause RV and RA flow disturbances as well as chamber remodeling, future studies will require characterization of TR severity to investigate its association with vorticity.
As a highly load-dependent chamber, correlating vorticity and echocardiographic measurements performed at different time points is prone to potential variable loading conditions that may confound these comparisons. To minimize the possibility of variable loading conditions, 4D flow CMR and echocardiography were performed sequentially on the same day to minimize this potential. Although phase contrast CMR has been used to assess LV diastolic function using trans-mitral inflow patterns, this technique has not been validated for the determination of RV diastolic function (15) . Subsequently, because echocardiography is the current noninvasive goldstandard for RV diastolic function, pulsed wave and tissue Doppler echocardiography was utilized as the comparator for vorticity instead of trans-tricuspid phase contrast CMR. Furthermore, in contrast to 4D CMR, the use of 2D phase contrast CMR would not allow for spatial renderings of vorticity and qualitative analysis of right heart complex blood flow patterns. An additional limitation is the use of echo-derived RVSP as a surrogate for invasive pulmonary hemodynamics, which introduces the potential for significant over-and underestimation of pulmonary artery systolic pressure (6) . Finally, because our PAH cohort includes both incident and prevalent cases, it is conceivable that pharmacologic treatment may alter right heart flow patterns and potentially confound our analysis.
